{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:04:34Z","timestamp":1775005474528,"version":"3.50.1"},"reference-count":3,"publisher":"PAGEPress Publications","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Transl Myol"],"abstract":"<jats:p>Dear Editor,\r\n\u00a0\r\nWe read the interesting letter to the Editor by Dr. Finsterer and appreciated the comments on our work. In this paper we aim at answering to the questions raised. \r\nFor the first point, Dr Finsterer suggests to add information about Nerve Conduction Studies (NCS) and needle Electromyography (EMG); unfortunately, we are not able to give the neurophysiological investigations acquired during the first admission at the hospital. Anyway, as regards the type of GBS, we can point out that he was diagnosed with an Acute Motor Axonal Neuropathy (AMAN), as stated by previous medical documents. Furthermore, we can confirm that the patient presented cranial nerve involvement, as evidenced by the ascending paralysis which involved trunk and head control, swallowing problems, mimic musculature deficits and respiratory impairment.[...]<\/jats:p>","DOI":"10.4081\/ejtm.2026.14916","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T15:22:02Z","timestamp":1770304922000},"source":"Crossref","is-referenced-by-count":0,"title":["Reply to &lt;i&gt;The outcome of severe Guillain-Barr\u00e9 syndrome \u00a0after robotic or conventional rehabilitation also depends on the triggering agent and the neurophysiological subtype&lt;\/i&gt;"],"prefix":"10.4081","volume":"36","author":[{"given":"Caterina","family":"Tramonti","sequence":"first","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi, Firenze"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"213323","unstructured":"1. Finsterer J. The outcome of severe Guillain-Barr\u00e9 syndrome after robotic or conventional rehabilitation also depends on the triggering agent and the electrophysiological subtype. Eur J Transl Myol doi: 10.4081\/ejtm.2025.1237214516"},{"key":"213324","doi-asserted-by":"crossref","unstructured":"2. Finsterer J. Triggers of Guillain-Barr\u00e9 Syndrome: Campylobacter jejuni Predominates. Int J Mol Sci 2022;23:14222.","DOI":"10.3390\/ijms232214222"},{"key":"213325","doi-asserted-by":"crossref","unstructured":"3. Gao Q, Xiao K, Tian D, Hu W, Han Z Lin J. Efficacy of therapies in the treatment of Guillain-Barre syndrome. A network meta-analysis. Medicine (Baltimore) 2021;100:e27351.","DOI":"10.1097\/MD.0000000000027351"}],"container-title":["European Journal of Translational Myology"],"original-title":[],"link":[{"URL":"https:\/\/www.pagepressjournals.org\/bam\/article\/download\/14916\/13698","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepressjournals.org\/bam\/article\/download\/14916\/13698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:02:05Z","timestamp":1775001725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pagepressjournals.org\/bam\/article\/view\/14916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":3,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,31]]}},"URL":"https:\/\/doi.org\/10.4081\/ejtm.2026.14916","relation":{},"ISSN":["2037-7460","2037-7452"],"issn-type":[{"value":"2037-7460","type":"electronic"},{"value":"2037-7452","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,5]]}}}